FIELD: medicine, in particular, ophthalmology. SUBSTANCE: essence of this method resides in studying such humoral immunity parameters as secretory and serum immunoglobulins of class A in case of such complications as photophobia, persistent eyewatering and rough cicatrization of incisions. Whenever content of secretory immunoglobulin A drops below level of 1.42 + 0.03 mg/ml and content of serum immunoglobulin A diminishes to less than 1.15 + 0.081 mg/ml, disclosed method prescribes carrying out immunocorrection by subcutaneously administering tactivin in daily dose of 100 mcg during three days, 1.5 g of essenciale a day, 100,000 IU of retinol acetate a day, and 300 mg of tocopherol acetate a day during three weeks. EFFECT: elimination of such complications as persistent eyewatering, photophobia; soft cicatrization of incisions; high acuity of vision; post-operative period reduced on the average by 4.6 + 0.23 bed/day and outpatient treatment period curtailed by 37.82 + 5.51 days.
Title | Year | Author | Number |
---|---|---|---|
METHOD TO TREAT MYOPIA | 1994 |
|
RU2106843C1 |
METHOD OF PROGNOSIS OF COMPLICATIONS AT KERATOTOMY | 1991 |
|
RU2019833C1 |
METHOD OF CORNEA TREATMENT IN ANTERIOR RADIAL KERATOTOMY | 0 |
|
SU1771726A1 |
METHOD OF BIMODAL IMPACT ON INJURED HUMAN TISSUE | 2010 |
|
RU2436522C1 |
METHOD FOR CORNEA TREATMENT | 0 |
|
SU1803077A1 |
METHOD FOR CORRECTION OF BIOMECHANICAL INSTABILITY AND IRREGULARITY OF CORNEA IN PATIENTS WITH CATARACT WITH PRESENCE OF ANTERIOR RADIAL KERATOTOMY IN ANAMNESIS | 2023 |
|
RU2826789C1 |
METHOD OF TREATING PROGRESSING HYPERMETROPIC SHIFT AFTER KERATOTOMY IN CASE OF NORMAL INTRAOCULAR PRESSURE | 2016 |
|
RU2612001C1 |
OPHTHALMIC OINTMENT | 2007 |
|
RU2331408C1 |
MYOPIA CORRECTION METHOD | 0 |
|
SU993936A2 |
METHOD OF TREATMENT OF CORNEA ULCERS OF PSEUDOMONAS AND GONOCOCCAL AETIOLOGY | 2006 |
|
RU2330633C1 |
Authors
Dates
1994-10-30—Published
1991-06-21—Filed